Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 5|pp. 7549–7569
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Back to articleFigure 7(7 of 9)
100%
Figure 7
Figure 7.Forest plots showing that ginsenoside Rg1 decreased the content of (A) IL-1β and (B) IL-6 compared with a control.